MONTAGUE MEDICAL PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: B81013 | GOOLE, DN14 6JD
Showing results 51-100 of 582
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Other emollient preparations | 846 | 425.2K | £5.5K | +40.8% ▲ |
| Venlafaxine | 828 | 27.3K | £5.1K | -2.0% ▼ |
| Folic acid | 818 | 24.2K | £530 | -37.0% ▼ |
| Montelukast | 784 | 21.3K | £1.1K | +14.5% ▲ |
| Semaglutide | 753 | 10.9K | £58.2K | +212.7% ▲ |
| Indapamide | 749 | 21.4K | £905 | -13.2% ▼ |
| 746 | 397.0K | £3.9K | -24.2% ▼ | |
| 733 | 10.5K | £6.8K | +10.3% ▲ | |
| Empagliflozin | 726 | 18.7K | £23.3K | +16.0% ▲ |
| Tramadol hydrochloride | 703 | 61.5K | £2.2K | -1.9% vs avg |
| Rivaroxaban | 691 | 19.7K | £13.3K | +12.9% ▲ |
| Bendroflumethiazide | 669 | 20.2K | £322 | -13.5% ▼ |
| Dapagliflozin | 667 | 17.4K | £21.6K | -46.7% ▼ |
| Glucose blood testing reagents | 664 | 69.6K | £9.5K | -15.9% ▼ |
| Edoxaban | 653 | 19.0K | £31.6K | -6.8% ▼ |
| Codeine phosphate | 646 | 43.5K | £1.4K | -10.1% ▼ |
| Solifenacin | 616 | 19.2K | £741 | +29.1% ▲ |
| Alendronic acid | 612 | 2,508 | £1.9K | -18.4% ▼ |
| Lactulose | 611 | 350.8K | £3.3K | +85.6% ▲ |
| Senna | 605 | 29.5K | £685 | +0.5% vs avg |
| 596 | 596 | £26.4K | +91.9% ▲ | |
| 590 | 1,189 | £42.3K | +8.2% ▲ | |
| Fluticasone/umeclidinium/vilanterol | 580 | 595 | £25.2K | +147.4% ▲ |
| Lamotrigine | 575 | 41.9K | £4.0K | -2.6% ▼ |
| Cetirizine hydrochloride | 565 | 24.1K | £1.0K | +13.1% ▲ |
| Sildenafil (Erectile Dysfunction) | 538 | 3,988 | £546 | +6.7% ▲ |
| Cyanocobalamin | 537 | 23.2K | £2.5K | +52.1% ▲ |
| Olanzapine | 535 | 10.2K | £1.1K | +44.4% ▲ |
| Latanoprost | 531 | 5,898 | £2.3K | +9.4% ▲ |
| Ezetimibe | 527 | 14.9K | £2.6K | -25.9% ▼ |
| Morphine sulfate | 522 | 58.8K | £3.1K | -20.4% ▼ |
| Warfarin sodium | 513 | 20.3K | £692 | +8.8% ▲ |
| Flucloxacillin sodium | 508 | 20.5K | £1.2K | +13.0% ▲ |
| Thiamine hydrochloride | 502 | 23.8K | £641 | -4.8% ▼ |
| Diclofenac diethyl | 489 | 54.0K | £5.0K | +37.7% ▲ |
| Sumatriptan succinate | 487 | 4,601 | £4.8K | +37.5% ▲ |
| Famotidine | 483 | 16.3K | £10.2K | -1.0% vs avg |
| Doxycycline hyclate | 472 | 5,433 | £506 | -7.9% ▼ |
| Budesonide | 469 | 535 | £13.3K | -13.5% ▼ |
| Levetiracetam | 466 | 36.6K | £5.7K | +1.8% vs avg |
| Insulin aspart | 465 | 3,142 | £20.9K | +22.1% ▲ |
| Mirabegron | 461 | 12.6K | £11.6K | +14.8% ▲ |
| Glyceryl trinitrate | 460 | 812 | £1.3K | +94.5% ▲ |
| Carvedilol | 445 | 22.2K | £757 | +292.2% ▲ |
| Mebeverine hydrochloride | 427 | 33.7K | £2.1K | +37.5% ▲ |
| Quetiapine | 426 | 19.8K | £4.5K | -31.6% ▼ |
| Spironolactone | 423 | 11.7K | £1.5K | -21.5% ▼ |
| 414 | 48.6K | £1.3K | +49.7% ▲ | |
| Hydrocortisone | 405 | 10.1K | £1.5K | -9.7% ▼ |
| Carbamazepine | 394 | 37.9K | £2.3K | +32.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.